Elisabetta A. Renzoni
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 168 publications
Navigating evidence-based recommendations for the management of systemic sclerosis.
Journal: Nature reviews. Rheumatology
Published: July 16, 2026
Does bronchoalveolar lavage lymphocytosis predict prognosis in fibrotic hypersensitivity pneumonitis, and is this relationship influenced by low-dose immunomodulatory therapy at the time of BAL?
Journal: Frontiers in medicine
Published: May 10, 2026
BAL cells analysis and lung function parameters in fibrotic hypersensitivity pneumonitis at baseline and in relation to survival.
Journal: Respiratory investigation
Published: November 03, 2025
Reply: From the authors of the ERS/ATS statement on the international multidisciplinary classification of the interstitial pneumonias.
Journal: The European respiratory journal
Published: October 23, 2025
Conspiracy Theories, MDTs and Communication.
Journal: Respirology (Carlton, Vic.)
Published: October 01, 2025
Reply: The rationale for distinguishing RB-ILD and AMP.
Journal: The European respiratory journal
Published: September 22, 2025
Reply: Bronchiolocentric interstitial pneumonia is a morphological term used for lung biopsy and chest imaging pattern and is not a substitute for hypersensitivity pneumonitis.
Journal: The European respiratory journal
Published: September 19, 2025
Assessment of noninvasive parameters prior to diagnosis of pulmonary hypertension in patients with fibrotic interstitial lung disease.
Journal: ERJ open research
Published: September 09, 2025
Treating sarcoidosis: when less is more.
Journal: Current opinion in immunology
Published: September 07, 2025
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG).
Journal: Annals of the rheumatic diseases
Published: September 05, 2025
Nintedanib in systemic sclerosis-associated interstitial lung disease: real-world cohort study on tolerability and discontinuation.
Journal: Clinical and experimental rheumatology
Published: August 25, 2025
Last Updated: 09/26/2026